Atar, Dan
Dan Atar
VIAF ID: 6598991 ( Personal )
Permalink: http://viaf.org/viaf/6598991
Preferred Forms
- 200 _ | ‡a Atar ‡b Dan
- 100 1 _ ‡a Atar, Dan
- 100 1 _ ‡a Atar, Dan
- 100 1 _ ‡a Atar, Dan
-
-
-
- 100 1 0 ‡a Atar, Dan
- 100 0 _ ‡a Dan Atar
4xx's: Alternate Name Forms (5)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Antiplatelet therapy in ACS and A-Fib | |
Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease | |
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes : evidence from recent clinical trials | |
ESC Pocket Guidelines: Therapie des akuten Herzinfarktes bei Patienten mit persistierender ST-Streckenhebung | |
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? | |
Hyperkaliæmi og reduceret nyrefunktion hos hjerteinsufficiente patienter under behandling spironolacton : en retrospektiv analyse af 125 konskutivt valgte patienter | |
Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke : the AGrenox versus Aspirin Therapy evaluation (AGATE) trial | |
Operating room guide to cross sectional anatomy of the extremities and pelvis, c1989: | |
Pharmacogenomics in cardiovascular clinical trials | |
Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure : a randomized comparison | |
Wytyczne ESC dotyczące leczenia migotania przedsionków w 2016 roku, opracowane we współpracy z EACTS |